Hepatitis Monthly

Published by: Kowsar

Prevalence and Risk Factors for Obesity After Liver Transplantation: A Single-Center Experience

Mesut Akarsu 1 , * , Yasin Bakir 1 , Sedat Karademir 2 , Tarkan Unek 2 , Aylin Bacakoglu 2 and Ibrahim Astarcioglu 2
Authors Information
1 Division of Gastroenterology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey
2 Department of Hepatobiliary Surgery and Liver Transplantation, Dokuz Eylül University, Izmir, Turkey
Article information
  • Hepatitis Monthly: August 01, 2013, 13 (8); e7569
  • Published Online: August 1, 2013
  • Article Type: Research Article
  • Received: August 2, 2012
  • Revised: February 15, 2013
  • Accepted: May 25, 2013
  • DOI: 10.5812/hepatmon.7569

To Cite: Akarsu M, Bakir Y, Karademir S, Unek T, Bacakoglu A, et al. Prevalence and Risk Factors for Obesity After Liver Transplantation: A Single-Center Experience, Hepat Mon. 2013 ;13(8):e7569. doi: 10.5812/hepatmon.7569.

Abstract
Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol. 2006; 5(2): 77-85[PubMed]
  • 2. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl. 2004; 10(7): 886-97[DOI][PubMed]
  • 3. Nair S, Cohen DB, Cohen MP, Tan H, Maley W, Thuluvath PJ. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol. 2001; 96(3): 842-5[DOI][PubMed]
  • 4. Richards J, Gunson B, Johnson J, Neuberger J. Weight gain and obesity after liver transplantation. Transpl Int. 2005; 18(4): 461-6[DOI][PubMed]
  • 5. Verdonk RC, van den Berg AP, Slooff MJ, Porte RJ, Haagsma EB. Liver transplantation: an update. Neth J Med. 2007; 65(10): 372-80[PubMed]
  • 6. Nair S, Vanatta JM, Arteh J, Eason JD. Effects of obesity, diabetes, and prior abdominal surgery on resource utilization in liver transplantation: a single-center study. Liver Transpl. 2009; 15(11): 1519-24[DOI][PubMed]
  • 7. T. D. Correia MI, Rego LO, Lima AS. Post-liver transplant obesity and diabetes. Curr Opin Clin Nutr Metab Care. 2003; 6(4): 457-60[DOI][PubMed]
  • 8. Wawrzynowicz-Syczewska M, Karpinska E, Jurczyk K, Laurans L, Boron-Kaczmarska A. Risk factors and dynamics of weight gain in patients after liver transplantation. Ann Transplant. 2009; 14(3): 45-50[PubMed]
  • 9. Gultekin T, Ozer BK, Akin G, Bektas Y, Sagir M, Gulec E. Prevalence of overweight and obesity in Turkish adults. Anthropol Anz. 2009; 67(2): 205-12[PubMed]
  • 10. Hatemi H, Yumuk VD, Turan N, Arik N. Prevalence of overweight and obesity in Turkey. Metab Syndr Relat Disord. 2003; 1(4): 285-90[DOI][PubMed]
  • 11. Everhart JE, Lombardero M, Lake JR, Wiesner RH, Zetterman RK, Hoofnagle JH. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg. 1998; 4(4): 285-96[PubMed]
  • 12. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation. 2000; 69(5): 781-9[PubMed]
  • 13. Neal DA, Gimson AE, Gibbs P, Alexander GJ. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight. Liver Transpl. 2001; 7(6): 533-9[DOI][PubMed]
  • 14. Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl. 2008; 14(11): 1648-54[DOI][PubMed]
  • 15. Rabkin JM, Corless CL, Rosen HR, Olyaei AJ. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg. 2002; 183(5): 595-9[PubMed]
  • 16. Richardson RA, Garden OJ, Davidson HI. Reduction in energy expenditure after liver transplantation. Nutrition. 2001; 17(7-8): 585-9[PubMed]
  • 17. Canzanello VJ, Schwartz L, Taler SJ, Textor SC, Wiesner RH, Porayko MK, et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg. 1997; 3(1): 1-9[PubMed]
  • 18. Stegall MD, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation. 1995; 60(9): 1057-60[PubMed]
  • 19. Palmer M, Schaffner F, Thung SN. Excessive weight gain after liver transplantation. Transplantation. 1991; 51(4): 797-800[PubMed]
  • 20. Krentz AJ, Dousset B, Mayer D, McMaster P, Buckels J, Cramb R, et al. Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients. Diabetes. 1993; 42(12): 1753-9[PubMed]
  • 21. Becker T, Foltys D, Bilbao I, D'Amico D, Colledan M, Bernardos A, et al. Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation. 2008; 86(12): 1689-94[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments